16 May 2018
More than half of antibiotics sold in Russia are manufactured locally, said the Deputy Minister of industry and Trade of Russia Sergey Tsyb at the meeting of the Expert Council on Health Care under the Federation Council Committee on Social Policy.
According to the official, today, Russian companies are actively investing and working on new generation antibiotics. The Deputy Minister of Industry and Trade said that the development of new antibiotics is a priority project for the Ministry.
“We will develop our own competencies and our own manufacturing,” promised Mr. Tsyb to participants of the Expert Council meeting.
To speed up the production of new drugs, the Russian Ministry of Industry and Trade will provide subsidies to developers.
According to Lyudmila Kozlova, Deputy Chair of the Federation Council Committee on Social Policy, the uncontrolled use of antimicrobials in health care, veterinary medicine and agriculture leads to the emergence of antibiotic resistance.
If the issue of antibiotic resistance is not addressed in the near future, then, by 2050, new strains of microorganisms may cause ten million deaths a year worldwide. For comparison, cancer, which is called the “plague of the 21st century,” causes two million deaths a year.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024